This dual action on both the JAK-STAT and NF-κB pathways suggests that CBG may offer a comprehensive approach to mitigating the inflammatory processes in AD while simultaneously enhancing skin barrier function. The gene discussed is SOAT1; the disease is Alzheimer disease.